Ankara: The weight-loss drug semaglutide reduces the risk of heart attacks and strokes, regardless of the amount of weight lost, according to a new study.
According to Anadolu Agency, the study, published this week in The Lancet, said that drugs suc…
Ankara: The weight-loss drug semaglutide reduces the risk of heart attacks and strokes, regardless of the amount of weight lost, according to a new study.
According to Anadolu Agency, the study, published this week in The Lancet, said that drugs suc…
Ankara: The weight-loss drug semaglutide reduces the risk of heart attacks and strokes, regardless of the amount of weight lost, according to a new study.
According to Anadolu Agency, the study, published this week in The Lancet, said that drugs suc…